Mean Systemic Filling Pressure and Heart Performance Predicting Fluid Responsiveness in Aortic Valve Replacement
1 other identifier
observational
27
1 country
1
Brief Summary
The purpose of this study is to determine fluid responsiveness in critically ill patients by measuring mean systemic filling pressure on the intensive care unit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2015
CompletedFirst Submitted
Initial submission to the registry
May 18, 2016
CompletedFirst Posted
Study publicly available on registry
May 20, 2016
CompletedDecember 18, 2019
December 1, 2019
1.4 years
May 18, 2016
December 16, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean systemic filling pressure (Pms)
An increase in mean systemic filling pressure after (self)volume-challenge indicating volume responsiveness of the patient
1 hour
Secondary Outcomes (1)
Heart performance (eH)
1 hour
Other Outcomes (12)
Heart Rate
1 hour
MAP
1 hour
CI
1 hour
- +9 more other outcomes
Study Arms (1)
Aortic Valve Replacement
Post Anaesthetic Care Unit (PACU) patients treated with aortic valve replacement (AVR) are highly eligible for this study.These are patients with an indication for fast track treatment (PACU) post-cardiac surgery with a good left ventricular ejection fraction without significant co-morbidity. The final decision for PACU-classification is taken by the responsible anaesthesiologist and intensivist in close collaboration with the cardiothoracic surgeon performing the operation, as well as the cardiologist.
Eligibility Criteria
Post-aortic valve replacement patients
You may qualify if:
- Patients must be older than 18 years, and must be equipped with a pulse-contour cardiac output system with a central venous catheter.
- Patients will be subsequently connected to the hemodynamic monitoring device Navigator™.
- In those patients with clinical signs of inadequate tissue perfusion, passive leg raising and standardized fluid challenge will be performed.
You may not qualify if:
- Patients with assist devices (e.g. intra aortic balloon pump, Impella®, ECMO), patients with arrhythmias (either atrial of ventricular) will be excluded from the study.
- Also, patients with inguinal impairment or contraindications for a passive leg raising will be excluded (such as deep venous thrombosis or elastic compression stocking), head trauma, an increase intra-abdominal pressure suspected by clinical context and examination as well as patients with absolute contraindications for fluid challenge.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Catharina Ziekenhuis Eindhovenlead
- Erasmus Medical Centercollaborator
Study Sites (1)
Catharina Hospital
Eindhoven, North Brabant, 5623 EJ, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jan Bakker, MD, PhD
Erasmus Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD-candidate Intensive Care Unit / resident cardiology
Study Record Dates
First Submitted
May 18, 2016
First Posted
May 20, 2016
Study Start
August 1, 2013
Primary Completion
January 1, 2015
Study Completion
January 1, 2015
Last Updated
December 18, 2019
Record last verified: 2019-12
Data Sharing
- IPD Sharing
- Will not share
No, data remain anonymized within hospital and property of PI.